Loading…
The use of bioreactors as in vitro models in pharmaceutical research
Bringing a new drug to market is costly in terms of capital and time investments, and any development issues encountered during late-stage clinical trials can often be the result of in vitro-in vivo extrapolations (IVIVE) not accurately reflecting clinical outcome. In the discipline of drug metaboli...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Default Article |
| Published: |
2013
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/2134/14245 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|